comparemela.com

Page 7 - Cuban Soberana News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Brief, powered by FACEBOOK – Vaccine geopolitics – EURACTIV com

In any civilisation, one commodity is more precious than the others, and it naturally becomes the bedrock of power. Could be salt, could be gold, could be the US dollar. Now it’s the COVID-19 vaccines. Unsurprisingly, the big geopolitical centres lost no time in joining the vaccine “gold rush”. And they reacted in their own ways. Centralised economies such as Russia, China, even tiny Cuba, mobilised as if it were wartime and produced their national vaccines in a record time. Liberal economies played the card of public-private partnerships and gave money to multinational companies to speed up the production of the precious commodity.

Argentina pays close attention to Soberana 02 vaccine s advances

Argentina pays close attention to Soberana 02 vaccine s advances Argentina pays close attention to Soberana 02 vaccine s advances Buenos Aires, Feb 23 (Prensa Latina) The advances of the Cuban Soberana 02 vaccine candidate, the first Latin American vaccine against Covid-19, were highlighted on Tuesday by the Director of Science and Innovation of the company BioCubaFarma, Rolando Perez Rodriguez. In an exclusive interview with the Pagina 12 newspaper, the Doctor in Biological Sciences noted that as of the second semester of 2021, Cuba will be able to immunize its population and provide doses to the countries that require them. Leading up to the 3rd phase of Soberana 02 clinical trial, with a production of 100 million doses for 2021, Perez Rodriguez underscored that at the end of March, another Cuban vaccine candidate, Abdala, developed by the Center for Genetic Engineering and Biotechnology (CIGB), will join the last phase of clinical trials.

Cuba produces first batch of 150,000 vial bottles of Covid-19 vaccine

Cuba produces first batch of 150,000 vial bottles of Covid-19 vaccine Cuba produces first batch of 150,000 vial bottles of Covid-19 vaccine Havana, Feb 10 (Prensa Latina) The Cuban biopharmaceutical industry produced the first batch of 150,000 vial bottles of Soberana 02, the most advanced Covid-19 vaccine candidate, which will start phase III of clinical trials in March, the developers highlighted. The large-scale production of the Cuban vaccine is aimed at providing sufficient doses to carry out the third phase of the study, according to the Twitter account of the Finlay Institute of Vaccines (IFV). The second batch is already being produced, IFV Director Vicente Verez said at a recent meeting between the Government and scientists, a fact that he also described as an important scientific-technological milestone.

Sputnik: Venezuela to receive first 10-mln doses of Russia s Vaccine

  Venezuela will receive the first consignment of 10 million doses of Russia s Sputnik V vaccine against COVID-19 in the upcoming weeks, President Nicolas Maduro said during his speech to the nation on Tuesday. The Russian ambassador has just given me the good news that the first 10 million Sputnik V vaccines will come to Venezuela very soon to ensure mass vaccination of those sectors of the population who need it most, Maduro said. The president also added that the Bolivarian Alliance for the Peoples of Our America (ALBA) is assessing the effectiveness of four vaccines, including the Cuban Soberana 02 vaccine against COVID-19.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.